In an illustrative application, we tested as a hypothesis of interest that the EGFR 15/18 bp deletions found in 5–20% of non-small cell lung cancers might have arisen during the development of normal lung tissue and been enriched due to a selective replication advantage [10]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.